Latin America includes a portfolio of locally recognised and trusted brands sold across the public and private sector. Brazil and Mexico are the biggest contributors to regional performance.
- The Brazilian private pharmaceutical market declined 3%, negatively impacted by foreign exchange movements and was valued by IQVIA at USD26 billion, while the Brazilian pharmaceutical market in local currency grew 11% for the year 30 June 2020.
Source: IQVIA – June 2020
Number of products launched:
Average staff turnover*:
Number of product recalls:
Number of work-related fatalities:
* Rate excludes employees transferred in Nutritionals disposal.
|Number of permanent employees|
|Regional Brands||2 342||2 136||10|
|Sterile Focus Brands||1 070||957||12|
|Total||3 412||3 093||10|
Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.